Tokenized stocks on the Solana blockchain reached a new daily trading volume record of $553 million on June 24, 2026, capturing nearly all global on-chain equity trading with about 95-98% market share. This surge is driven by platforms like Backpack, offering fractional shares of private companies such as SpaceX, and Sunrise DeFi, enabling 24/7 trading and DeFi integration. Solana's low fees and high speed make it ideal for retail investors trading small amounts, expanding the user base beyond whales. While regulatory and concentration risks remain, the $10 billion cumulative volume milestone signals tokenized equities are becoming a mainstream alternative market, with Solana leading this shift.
Axsome Therapeutics received an "Outperform" rating from BMO Capital due to significant progress in its drug pipeline, including FDA acceptance of its NDA for AXS-12, a narcolepsy treatment with a PDUFA date set for May 1, 2027. The company is also a...
Novartis is set to report its Q2 earnings with analysts expecting an EPS of $2.17 and revenue of $14.07 billion, following a tough Q1 affected by major patent expirations. Despite revenue challenges, the company maintained strong cash flow of $3.30 b...
KeyCorp is set to report earnings with analysts forecasting a 20% increase in earnings per share to $0.42 and an 8% rise in total revenue to $1.97 billion. The growth is mainly driven by a 10% increase in net interest income, fueled by strong commerc...
Several biotech and manufacturing companies saw significant stock declines due to key corporate events. Vision Marine Technologies dropped nearly 24% after shifting its focus from boat manufacturing to a mining project, causing investor uncertainty. ...
Shares of Zhengye Biotechnology surged over 1047% to regain Nasdaq compliance after a minimum bid price warning. Advanced Biomed and Axe Compute also saw notable gains following a reverse stock split and Russell Microcap Index inclusion, respectively...
